| Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome CI Kang, SH Kim, WB Park, KD Lee, HB Kim, EC Kim, M Oh, KW Choe Antimicrobial agents and chemotherapy 49 (2), 760-766, 2005 | 839 | 2005 |
| The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial WB Park, NH Kim, KH Kim, SH Lee, WS Nam, SH Yoon, KH Song, ... Clinical Infectious Diseases 55 (8), 1080-1087, 2012 | 436 | 2012 |
| Bloodstream Infections Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment … CI Kang, SH Kim, WB Park, KD Lee, HB Kim, EC Kim, MD Oh, KW Choe Antimicrobial agents and chemotherapy 48 (12), 4574-4581, 2004 | 379 | 2004 |
| Virus isolation from the first patient with SARS-CoV-2 in Korea WB Park, NJ Kwon, SJ Choi, CK Kang, PG Choe, JY Kim, J Yun, GW Lee, ... Journal of Korean Medical Science 35 (7), 2020 | 301 | 2020 |
| Epidemiology and Clinical Features of Bloodstream Infections Caused by AmpC-Type-β-Lactamase-Producing Klebsiella pneumoniae H Pai, CI Kang, JH Byeon, KD Lee, WB Park, HB Kim, EC Kim, M Oh, ... Antimicrobial agents and chemotherapy 48 (10), 3720-3728, 2004 | 287 | 2004 |
| A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein C Kim, DK Ryu, J Lee, YI Kim, JM Seo, YG Kim, JH Jeong, M Kim, JI Kim, ... Nature communications 12 (1), 288, 2021 | 268 | 2021 |
| MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015 PG Choe, R Perera, WB Park, KH Song, JH Bang, ES Kim, HB Kim, ... Emerging infectious diseases 23 (7), 1079, 2017 | 267 | 2017 |
| Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea M Oh, WB Park, SW Park, PG Choe, JH Bang, KH Song, ES Kim, HB Kim, ... The Korean journal of internal medicine 33 (2), 233, 2018 | 248 | 2018 |
| Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection ES Kim, PG Choe, WB Park, HS Oh, EJ Kim, EY Nam, SH Na, M Kim, ... Journal of Korean medical science 31 (11), 1717-1725, 2016 | 232 | 2016 |
| Viral load kinetics of MERS coronavirus infection M Oh, WB Park, PG Choe, SJ Choi, JI Kim, J Chae, SS Park, EC Kim, ... New England Journal of Medicine 375 (13), 1303-1305, 2016 | 225 | 2016 |
| In Vitro Activities of 28 Antimicrobial Agents against Staphylococcus aureus Isolates from Tertiary-Care Hospitals in Korea: a Nationwide Survey HB Kim, HC Jang, HJ Nam, YS Lee, BS Kim, WB Park, KD Lee, YJ Choi, ... Antimicrobial agents and chemotherapy 48 (4), 1124-1127, 2004 | 193 | 2004 |
| A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea ES Kim, JS Song, HJ Lee, PG Choe, KH Park, JH Cho, WB Park, SH Kim, ... Journal of Antimicrobial Chemotherapy 60 (5), 1108-1114, 2007 | 192 | 2007 |
| Severe fever with thrombocytopenia syndrome in South Korea, 2013-2015 SJ Choi, SW Park, IG Bae, SH Kim, SY Ryu, HA Kim, HC Jang, J Hur, ... PLoS neglected tropical diseases 10 (12), e0005264, 2016 | 177 | 2016 |
| One‐year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients WB Park, PG Choe, SH Kim, JH Jo, JH Bang, HB Kim, NJ Kim, M Oh, ... Journal of internal medicine 261 (3), 268-275, 2007 | 176 | 2007 |
| Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea WB Park, RAPM Perera, PG Choe, EHY Lau, SJ Choi, JY Chun, HS Oh, ... Emerging infectious diseases 21 (12), 2186, 2015 | 174 | 2015 |
| Posttraumatic stress disorder and depression of survivors 12 months after the outbreak of Middle East respiratory syndrome in South Korea HY Park, WB Park, SH Lee, JL Kim, JJ Lee, H Lee, HS Shin BMC public health 20, 1-9, 2020 | 160 | 2020 |
| Salvage Treatment for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Efficacy of Linezolid With or Without Carbapenem HC Jang, SH Kim, KH Kim, CJ Kim, S Lee, KH Song, JH Jeon, WB Park, ... Clinical infectious diseases 49 (3), 395-401, 2009 | 153 | 2009 |
| Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia? S Lee, PG Choe, KH Song, SW Park, HB Kim, NJ Kim, EC Kim, WB Park, ... Antimicrobial agents and chemotherapy 55 (11), 5122-5126, 2011 | 148 | 2011 |
| Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae CI Kang, SH Kim, DM Kim, WB Park, KD Lee, HB Kim, M Oh, EC Kim, ... Infection Control & Hospital Epidemiology 25 (10), 860-867, 2004 | 144 | 2004 |
| Antibody responses 8 months after asymptomatic or mild SARS-CoV-2 infection PG Choe, KH Kim, CK Kang, HJ Suh, EK Kang, SY Lee, NJ Kim, J Yi, ... Emerging infectious diseases 27 (3), 928, 2021 | 142 | 2021 |
